NCT06625775
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06625775
Title Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Acronym BREAKER-101
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS